This article is more than 5 years old. Information may no longer be current.
Epidemiologist joins Cedars-Sinai
Click Here to Manage Email Alerts
Epidemiologist Christie Y. Jeon, ScD, has joined Cedars-Sinai as a research scientist in the Samuel Oschin Comprehensive Cancer Institute, specializing in cancer prevention and control.
“The study of epidemiology is a branch of medicine that focuses on the causes, distribution and control of diseases,” Marc Troup Goodman, PhD, MPH, director of Cedars-Sinai’s cancer prevention and control program, said in a press release. “By adding Dr. Jeon to our team, we are taking a leap forward toward deepening our understanding of how cancer works and how we can best develop new treatments for our patients.”
Goodman and Jeon will focus on advancing the study of how the environment and biology affect the progression of disease. Jeon’s research at Cedars-Sinai will focus on how liver, pancreatic and gastrointestinal cancers correlate to diabetes and infectious diseases. She also will investigate prevention strategies for infection-associated cancers and global health disparities.